Back
ZyVersa Therapeutics Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
8
ZVSA
ZyVersa Therapeutics
Last Price:
1.12
Seasonality Move:
-78.1%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ZVSA is experiencing buying pressure, which is a positive indicator for future bullish movement.
ZyVersa Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.17 | Sell |
| 20-day SMA: | 1.54 | Sell |
| 50-day SMA: | 1.98 | Sell |
| 200-day SMA: | 4.44 | Sell |
| 8-day EMA: | 1.22 | Sell |
| 20-day EMA: | 1.48 | Sell |
| 50-day EMA: | 1.96 | Sell |
| 200-day EMA: | 41.76 | Sell |
ZyVersa Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.28 | Sell |
| Relative Strength Index (14 RSI): | 32.04 | Sell |
| Chaikin Money Flow: | 123461 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.21 - 2.11) | Sell |
| Bollinger Bands (100): | (1.74 - 3.62) | Sell |
ZyVersa Therapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for ZyVersa Therapeutics Stock
Is ZyVersa Therapeutics Stock a Buy?
- ZyVersa Therapeutics share price is 1.13 while ZVSA 8-day simple moving average is 1.17, which is a Sell signal.
- The stock price of ZVSA is 1.13 while ZyVersa Therapeutics 20-day SMA is 1.54, which makes it a Sell.
- ZyVersa Therapeutics 50-day simple moving average is 1.98 while ZVSA share price is 1.13, making it a Sell technically.
- ZVSA stock price is 1.13 and ZyVersa Therapeutics 200-day simple moving average is 4.44, creating a Sell signal.
ZVSA Technical Analysis vs Fundamental Analysis
Sell
8
ZyVersa Therapeutics (ZVSA)
is a Sell
Is ZyVersa Therapeutics a Buy or a Sell?
-
ZyVersa Therapeutics stock is rated a Sell
The current ZyVersa Therapeutics [ZVSA] share price is $1.13. The Score for ZVSA is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
ZyVersa Therapeutics Stock Info
Market Cap:
2.65M
Price in USD:
1.13
Share Volume:
132.61K
ZyVersa Therapeutics 52-Week Range
52-Week High:
42.39
52-Week Low:
1.04
Sell
8
ZyVersa Therapeutics (ZVSA)
is a Sell
ZyVersa Therapeutics Share Price Forecast
-
What is the ZyVersa Therapeutics stock price today?
The ZyVersa Therapeutics stock price is 1.13 USD today. -
Will ZVSA stock go up or go down?
ZyVersa Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is ZyVersa Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, ZyVersa Therapeutics is overvalued.
Is ZyVersa Therapeutics Stock a Buy?
- ZyVersa Therapeutics share price is 1.13 while ZVSA 8-day exponential moving average is 1.22, which is a Sell signal.
- The stock price of ZVSA is 1.13 while ZyVersa Therapeutics 20-day EMA is 1.48, which makes it a Sell.
- ZyVersa Therapeutics 50-day exponential moving average is 1.96 while ZVSA share price is 1.13, making it a Sell technically.
- ZVSA stock price is 1.13 and ZyVersa Therapeutics 200-day simple moving average is 41.76, creating a Sell signal.
Fundamental Analysis of ZyVersa Therapeutics
Is ZyVersa Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $1.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $698.82 per share, and an increase next year of $11.20 per share.
Technical Analysis of ZyVersa Therapeutics
Should I short ZyVersa Therapeutics stock?
- ZVSA Moving Average Covergence Divergence (MACD) indicator is -0.28, suggesting ZyVersa Therapeutics is a Sell
- ZyVersa Therapeutics Relative Strength Index (RSI) is 32.04, which suggest ZyVersa Therapeutics is oversold
- The Bollinger Bands (25) for ZyVersa Therapeutics is (1.21 - 2.11), which suggest ZyVersa Therapeutics is a Sell
- The Bollinger Bands (100) for ZyVersa Therapeutics is (1.74 - 3.62), which suggest ZyVersa Therapeutics is a Sell
* ZyVersa Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.